These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22183772)

  • 1. Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior.
    Gueron G; De Siervi A; Vazquez E
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):213-21. PubMed ID: 22183772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammatory mediators enhance prostate cancer development and progression.
    Thapa D; Ghosh R
    Biochem Pharmacol; 2015 Mar; 94(2):53-62. PubMed ID: 25593038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
    Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
    FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and microenvironmental implications in prostate cancer progression and metastasis.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2008; 12(3):167-75. PubMed ID: 18700688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent role of inflammation in prostate diseases: chemoprevention development opportunity.
    Hamid AR; Umbas R; Mochtar CA
    Acta Med Indones; 2011 Jan; 43(1):59-65. PubMed ID: 21339547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR2 expression correlates with prostate cancer progression.
    Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
    J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
    Shiota M; Yokomizo A; Naito S
    Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment and metabolism in prostate cancer.
    Chiarugi P; Paoli P; Cirri P
    Semin Oncol; 2014 Apr; 41(2):267-80. PubMed ID: 24787298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate inflammation and its potential impact on prostate cancer: a current review.
    Haverkamp J; Charbonneau B; Ratliff TL
    J Cell Biochem; 2008 Apr; 103(5):1344-53. PubMed ID: 17955503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.
    Servais C; Erez N
    J Pathol; 2013 Jan; 229(2):198-207. PubMed ID: 22996812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer and inflammation: interaction of chemokines and hnRNPs.
    Tauler J; Mulshine JL
    Curr Opin Pharmacol; 2009 Aug; 9(4):384-8. PubMed ID: 19570713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib.
    Narayanan NK; Nargi D; Horton L; Reddy BS; Bosland MC; Narayanan BA
    Prostate; 2009 Feb; 69(2):133-41. PubMed ID: 18819100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines in liver inflammation and fibrosis.
    Wasmuth HE; Tacke F; Trautwein C
    Semin Liver Dis; 2010 Aug; 30(3):215-25. PubMed ID: 20665374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation: gearing the journey to cancer.
    Kundu JK; Surh YJ
    Mutat Res; 2008; 659(1-2):15-30. PubMed ID: 18485806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype.
    Smith AM; Findlay VJ; Bandurraga SG; Kistner-Griffin E; Spruill LS; Liu A; Golshayan AR; Turner DP
    Carcinogenesis; 2012 Mar; 33(3):572-80. PubMed ID: 22232738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells.
    Wang L; Alcon A; Yuan H; Ho J; Li QJ; Martins-Green M
    Integr Biol (Camb); 2011 Jul; 3(7):742-54. PubMed ID: 21594291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging roles of chemokines in prostate cancer.
    Vindrieux D; Escobar P; Lazennec G
    Endocr Relat Cancer; 2009 Sep; 16(3):663-73. PubMed ID: 19556286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.